Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
Mengjie Rui, Yang Qu, Tong Gao, Yanru Ge, Chunlai Feng, Ximing Xu Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang, People’s Republic of China Abstract: The development of drug resistance in cancer cells is one of the major obstacles to achieving effective c...
Guardado en:
Autores principales: | Rui M, Qu Y, Gao T, Ge Y, Feng C, Xu X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f5ead172efe415899e769adc8982537 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
por: Liuying Chen, et al.
Publicado: (2021) -
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
por: Tang L, et al.
Publicado: (2021) -
Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni S, et al.
Publicado: (2017) -
Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer
por: Pei W, et al.
Publicado: (2020) -
Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis
por: Ni Zeng, et al.
Publicado: (2021)